Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Tacrolimus Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- AKI
- Sponsor
- Qianfoshan Hospital
- Enrollment
- 1200
- Locations
- 1
- Primary Endpoint
- AKI
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
In this study, the investigators aim to develop a risk prediction model for acute kidney injury (AKI) in hospitalized patients using the calcineurin inhibitor tacrolimus. This will be achieved by mining electronic medical record data and employing explainable deep learning methods. The model will provide clinical decision support for timely intervention and treatment. Compared to traditional machine learning models, deep neural networks can extract more nuanced features from complex medical data and perform more precise pattern recognition, thereby enhancing prediction accuracy and reliability. By constructing a predictive tool based on explainable deep learning models, the investigators will better assess the association between the use of calcineurin inhibitors and AKI, explore targeted prevention strategies, and offer more precise predictions and intervention guidance to clinicians. Additionally, this research has significant socio-economic benefits and application potential. By reducing the incidence of AKI, the investigators can lower patient hospitalization duration and re-treatment costs, conserve medical resources, and improve patient quality of life. Preventive healthcare not only alleviates the physical and psychological burden on patients but also reduces the strain on the healthcare system, enhances healthcare efficiency, and promotes the rational allocation of medical resources.
Investigators
Xiao Li,MD
Associate professor of pharmacy
Qianfoshan Hospital
Eligibility Criteria
Inclusion Criteria
- •Use of tacrolimus during hospitalization, with standardized therapeutic drug monitoring
- •Age of 18 years or older at the time of admission
- •Length of hospital stay ≥ hours
- •At least two serum creatinine level tests conducted during the hospital stay
Exclusion Criteria
- •Stage 5 chronic kidney disease prior to admission
- •Incomplete clinical data
- •Serum creatinine levels consistently below 40 mmol/L during hospitalization
Outcomes
Primary Outcomes
AKI
Time Frame: From January 2020 to December 2023
Acute kidney injury occurred after the patient took tacrolimus during hospitalization